Evidence map›Paper›PMID 17018656›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2006

A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls.

Thomas O Carpenter, Maria C DeLucia, Jane Hongyuan Zhang, Gina Bejnerowicz, Lisa Tartamella, James Dziura, Kitt Falk Petersen, Douglas Befroy, Dorothy Cohen

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Dietary vitamin C intake and the risk of hip fracture: a dose-response meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Pooled it
  2. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. An update on magnesium and bone health.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2021
    Review
  17. Review
  18. CKD-MBD post kidney transplantation.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  19. Article
  20. Magnesium and Human Health: Perspectives and Research Directions.International journal of endocrinology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Thomas O CarpenterDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520-8064, USA. thomas.carpenter@yale.edu
Maria C DeLucia
Jane Hongyuan Zhang
Gina Bejnerowicz
Lisa Tartamella
James Dziura
Kitt Falk Petersen
Douglas Befroy
Dorothy Cohen
VA Connecticut Healthcare System · USYale New Haven Hospital · USYale University · US

Funding

Role of Mitochondrial Dysfunction in Insulin ResistanceP01DK068229 · NIDDK · YALE UNIVERSITY · PI ROTHMAN, DOUGLAS LYLE · 2004 to 2008
$7.0M
Mechanism of Insulin Resistance in the Aged.R01AG023686 · NIA · YALE UNIVERSITY · PI PETERSEN, KITT F · 2003 to 2014
$3.4M
DISORDERS OF MINERAL METABOLISM IN CHILDRENK24HD001288 · NICHD · YALE UNIVERSITY · PI CARPENTER, THOMAS O · 1999 to 2003
$429k
NIA NIH HHS R01 AG023686NICHD NIH HHS K24 HD001288NICHD NIH HHS K24-HD01288NIDDK NIH HHS P01 DK068229NIDDK NIH HHS P01-DK068229PHS HHS R01-AGG23686
6 · The paper itself

Abstract

contextThe role of magnesium (Mg) as a determinant of bone mass has not been extensively explored. Limited studies suggest that dietary Mg intake and bone mineral density are correlated in adults, but no data from interventional studies in children and adolescents are available.

objectiveWe sought to determine whether Mg supplementation in periadolescent girls enhances accrual of bone mass.

designWe carried out a prospective, placebo-controlled, randomized, one-year double-blind trial of Mg supplementation.

settingThe study was conducted in the Clinical Research Centers at Yale University School of Medicine. PATIENTS OR OTHER

participantsHealthy 8- to 14-yr-old Caucasian girls were recruited from community pediatricians' offices. Dietary diaries from over 120 volunteers were analyzed, and those with dietary Mg intake of less than 220 mg/d were invited to participate in the intervention.

interventionMagnesium (300 mg elemental Mg per day in two divided doses) or placebo was given orally for 12 months.

main outcome measureThe primary outcome measure was interval change in bone mineral content (BMC) of the total hip, femoral neck, Ward's area, and lumbar spine (L1-L4) after 12 months of Mg supplementation.

resultsSignificantly increased accrual (P = 0.05) in integrated hip BMC occurred in the Mg-supplemented vs. placebo group. Trends for a positive Mg effect were evident in the pre- and early puberty and in mid-late puberty. Lumbar spinal BMC accrual was slightly (but not significantly) greater in the Mg-treated group. Compliance was excellent; 73% of capsules were ingested as inferred by pill counts. Serum mineral levels, calciotropic hormones, and bone markers were similar between groups.

conclusionsOral Mg oxide capsules are safe and well tolerated. A positive effect of Mg supplementation on integrated hip BMC was evident in this small cohort.

Indexed as

Dietary SupplementsAdministration, OralAdolescentBone and BonesBone DensityChildDouble-Blind MethodFemaleHumansMagnesium OxidePatient CompliancePlacebosMagnesium OxidePlacebos

Identifiers

PMID17018656
PMCPMC2995550
OpenAlexW2105758201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.